Free Trial

Immix Biopharma (IMMX) SEC Filings & 10K Form

Immix Biopharma logo
$2.17 -0.05 (-2.25%)
(As of 12/20/2024 05:23 PM ET)

Recent Immix Biopharma SEC Filings

DateFilerForm TypeView
08/26/2024
3:45 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:45 PM
Immix Biopharma (Issuer)
Ng Carey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:16 PM
Immix Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
8:15 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:30 AM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
8:12 PM
Immix Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/19/2024
8:20 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:45 PM
Adams Helen C. (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
BUCHAN JANE (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Ng Carey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Chudnovsky Yekaterina (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:45 PM
Immix Biopharma (Issuer)
Marquet Magda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:30 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
8:00 AM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
8:00 AM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:00 AM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:00 AM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:27 PM
Immix Biopharma (Filer)
Form D
Notice of Exempt Offering of Securities 
05/20/2024
4:27 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
4:25 PM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:25 PM
Immix Biopharma (Issuer)
Ng Carey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:25 PM
Immix Biopharma (Issuer)
Marquet Magda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:25 PM
BUCHAN JANE (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:25 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:25 PM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:25 PM
Adams Helen C. (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:28 PM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:29 PM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
4:26 PM
Immix Biopharma (Filer)
Form DEF 14A
02/07/2024
4:15 PM
Immix Biopharma (Filer)
Form 424B5
02/07/2024
8:18 AM
HIRSCHMAN ORIN (Filed by)
Immix Biopharma (Subject)
Form SC 13G
02/06/2024
8:09 AM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:37 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:38 PM
Immix Biopharma (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMMX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners